Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20120215009014N289
IRCT20120215009014N289CompletedPhase 2

Effects of oral magnesium versus placebo on prevention of spinal anesthesia-induced headache after spinal anesthesia in women who undergo cesarean section: a double-blind randomized clinical trial

Hamedan University of Medical Sciences0 sites92 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
92
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to 45 years (—)
Sex
Female

Inclusion Criteria

  • •Age of 15 to 45 years
  • •Candidate for sectarian under spinal anesthesia

Exclusion Criteria

  • •History of migraine or headache
  • •Severe preeclampsia
  • •Sensitivity of magnesium

Investigators

Similar Trials

Not yet recruiting
Phase 2
Effect of oral magnesium sachet versus placebo on shivering after cesarean section under spinal anesthesia
IRCT20120215009014N374Hamedan University of Medical Sciences50
Recruiting
Phase 3
Effect of oral magnesium sachet versus placebo on treatment of post-dural puncture headache in pregnant women candidate for cesarean sectioHeadache.Other headache syndromes
IRCT20120215009014N433Hamedan University of Medical Sciences130
Completed
Phase 3
A comparative study of the effects of oral magnesium versus placebo in migraine prophylaxis in pregnancy periodCondition 1: Common Migraine. Condition 2: Classical Migraine.Migraine without aura (common migraine)Migraine with aura (classical migraine)
IRCT2016062128559N1Vice-chancellor for research, Kermanshah University of Medical Sciences64
Completed
Phase 3
Effect of oral magnesium supplementation on cardio metabolic markers in people at risk of diabetes
IRCT20181226042129N1Esfahan University of Medical Sciences84
Completed
Phase 2
The effect of magnesium supplementation on depressioDepression.This block contains disorders in which the fundamental disturbance is a change in affect or mood to depression (with or without associated anxiety) or to elation. The mood change is usually accompanied by a change in the overall level of activitymost ofF32, F33
IRCT2013121015744N1Research Council (Research and Technology) of Shahid Sadooghi University of Medical Sciences and Hea600